Finally, we immunostained breast cancer tissue sections from a murine-derived syngeneic transplant model14 for the CTL marker CD8 and found the immunostaining data was in good agreement with our RNAseq CTL score (Supplementary Fig. 3E). The gene discussed is CD8A; the disease is breast carcinoma.